Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/44537
Title: PIPAC Pharmacologic and Clinical Data
Authors: Cortes-Guiral, Delia
Kranenburg, Onno
Sgarbura, Olivia
VAN DER SPEETEN, Kurt 
Taibi, Albdelkader
Hubner, Martin
Yacoov, Almog Ben
Issue Date: 2024
Publisher: WILEY
Source: Journal of surgical oncology,
Status: Early view
Abstract: Pressurized intraperitoneal aerosol chemotherapy (PIPAC) emerged as an innovative intraperitoneal chemotherapy delivery system to overcome the issue of limited efficacy of systemic therapies to induce response in peritoneal malignancies. Promising results for patients with mesothelioma peritonei and peritoneal metastasis from gastric, ovarian, colorectal, pancreatic, and hepatobiliary tumors origin are changing the landscape for patients otherwise just facing palliative treatment. Ongoing trials will shed more light on the actual benefits of PIPAC.
Notes: Cortés-Guiral, D (corresponding author), Hosp Viamed Santa Elena, IVOQA Viamed Adv Surg Oncol Inst, Madrid, Spain.
delia.cortes.guiral@gmail.com
Keywords: clinical results;peritoneal metastasis;pharmacology;PIPAC
Document URI: http://hdl.handle.net/1942/44537
ISSN: 0022-4790
e-ISSN: 1096-9098
DOI: 10.1002/jso.27900
ISI #: 001318303800001
Rights: 2024 Wiley Periodicals LLC
Category: A1
Type: Journal Contribution
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
PIPAC Pharmacologic and Clinical Data.pdf
  Restricted Access
Early view354.3 kBAdobe PDFView/Open    Request a copy
Show full item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.